Protalix Biotherapeutics logo

Protalix Biotherapeutics Share Price Today

(NASDAQ: PLX)

Protalix Biotherapeutics share price is $2.61 & ₹223.06 as on 17 Apr 2025, 09.30 hrs IST

$2.61

0.01

(0.38%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Protalix Biotherapeutics share price in Dollar and Rupees. Guide to invest in Protalix Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Protalix Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Protalix Biotherapeutics share price movements

  • Today's Low: $2.59
    Today's High: $2.64

    Day's Volatility :2.08%

  • 52 Weeks Low: $0.82
    52 Weeks High: $2.76

    52 Weeks Volatility :70.24%

Protalix Biotherapeutics (PLX) Returns

PeriodProtalix Biotherapeutics IncIndex (Russel 2000)
3 Months
12.02%
0.0%
6 Months
146.23%
0.0%
1 Year
126.96%
0.0%
3 Years
64.15%
-12.9%

Protalix Biotherapeutics (PLX) Key Statistics

in dollars & INR

Previous Close
$2.6
Open
$2.61
Today's High
$2.64
Today's Low
$2.585
Market Capitalization
$203.7M
Today's Volume
$377.1K
52 Week High
$2.76
52 Week Low
$0.8214
Revenue TTM
$53.4M
EBITDA
$5.2M
Earnings Per Share (EPS)
$0.04
PE Ratio
65.25
Profit Margin
5.49%
Quarterly Earnings Growth YOY
-0.39%
Return On Equity TTM
7.64%

How to invest in Protalix Biotherapeutics Stock (PLX) from India?

It is very easy for Indian residents to invest directly in Protalix Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Protalix Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Protalix Biotherapeutics or PLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Protalix Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Protalix Biotherapeutics shares which would translate to 0.327 fractional shares of Protalix Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Protalix Biotherapeutics, in just a few clicks!

Returns in Protalix Biotherapeutics (PLX) for Indian investors in Rupees

The Protalix Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Protalix Biotherapeutics investment value today

Current value as on today

₹2,29,298

Returns

₹1,29,298

(+129.3%)

Returns from Protalix Biotherapeutics Stock

₹1,26,957 (+126.96%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Protalix Biotherapeutics (PLX)

-64%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Protalix Biotherapeutics Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Protalix Biotherapeutics

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Protalix Biotherapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Protalix Biotherapeutics Stock (PLX)

What analysts predicted

Upside of 455.56%

Target:

$14.50

Current:

$2.61

Insights on Protalix Biotherapeutics Stock (Ticker Symbol: PLX)

  • Price Movement

    In the last 7 days, PLX stock has moved up by 8.3%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 3.74M → 18.21M (in $), with an average increase of 32.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -6.04M → 6.49M (in $), with an average increase of 89.6% per quarter

PLX Protalix Biotherapeutics Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$53.4M
↓ 18.47%
Net Income
$2.9M
↓ 64.73%
Net Profit Margin
5.49%
↓ 7.2%

Protalix Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Protalix Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Protalix Biotherapeutics (PLX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Protalix Biotherapeutics Inc logo
10.59%
146.23%
126.96%
64.15%
64.15%
Regeneron Pharmaceuticals, Inc. logo
-15.01%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-12.04%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.13%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-7.49%
-19.67%
62.43%
39.66%
61.91%

About Protalix Biotherapeutics

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Organization
Protalix Biotherapeutics
Employees
213
CEO
Mr. Dror Bashan
Industry
Health Services

Management People of Protalix Biotherapeutics

NameTitle
Mr. Dror Bashan
President, CEO & Director
Mr. Eyal Rubin M.B.A.
Senior VP, CFO, Treasurer & Corporate Secretary
Mr. Yaron Naos
Senior Vice President of Operations
Ms. Yael Fellous
Vice President of Human Resources

Important FAQs about investing in PLX Stock from India :

What is Protalix Biotherapeutics share price today?

Protalix Biotherapeutics share price today stands at $2.61, Open: $2.61 ; Previous Close: $2.60 ; High: $2.64 ; Low: $2.59 ; 52 Week High: $2.76 ; 52 Week Low: $0.82.

The stock opens at $2.61, after a previous close of $2.60. The stock reached a daily high of $2.64 and a low of $2.59, with a 52-week high of $2.76 and a 52-week low of $0.82.

Can Indians buy Protalix Biotherapeutics shares?

Yes, Indians can invest in the Protalix Biotherapeutics (PLX) from India.

With INDmoney, you can buy Protalix Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Protalix Biotherapeutics at zero transaction cost.

How can I buy Protalix Biotherapeutics shares from India?

It is very easy to buy Protalix Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Protalix Biotherapeutics (PLX) be purchased?

Yes, you can buy fractional shares of Protalix Biotherapeutics with INDmoney app.

What are the documents required to start investing in Protalix Biotherapeutics stocks?

To start investing in Protalix Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Protalix Biotherapeutics Stock (PLX)?

Today’s highest price of Protalix Biotherapeutics (PLX) is $2.64.

Today’s lowest price of Protalix Biotherapeutics (PLX) is $2.59.

What is today's market capitalisation of Protalix Biotherapeutics?

Today's market capitalisation of Protalix Biotherapeutics PLX is 203.7M

What is the 52 Week High and Low Range of Protalix Biotherapeutics Stock (PLX)?

  • 52 Week High

    $2.76

  • 52 Week Low

    $0.82

What are the historical returns of Protalix Biotherapeutics (PLX)?

  • 1 Month Returns

    10.59%

  • 3 Months Returns

    146.23%

  • 1 Year Returns

    126.96%

  • 5 Years Returns

    64.15%

Who is the Chief Executive Officer (CEO) of Protalix Biotherapeutics ?

Mr. Dror Bashan is the current Chief Executive Officer (CEO) of Protalix Biotherapeutics.